FC
TXG icon

FORA Capital’s 10x Genomics TXG Stock Holding History

FORA Capital’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,677
Closed -$354K – 647
2024
Q4 		$354K Buy
+24,677
New +$389K 0.04% 299
2021
Q4 		– Sell
-4,298
Closed -$626K – 472
2021
Q3 		$626K Buy
+4,298
New +$738K 0.16% 172
2021
Q1 		– Sell
-7,374
Closed -$1.04M – 1112
2020
Q4 		$1.04M Buy
7,374
+3,951
+115% +$573K 0.16% 140
2020
Q3 		$427K Sell
3,423
-2,260
-40% -$237K 0.28% 77
2020
Q2 		$508K Buy
+5,683
New +$443K 0.17% 154

Other funds holding TXG

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FORA Capital's TXG Position: Q1 2025 in Review

FORA Capital sold out of 10x Genomics (TXG) in Q1 2025, closing a stake of 24,677 shares — an estimated $354K sold.

FORA Capital first reported a position in TXG in Q2 2020 and held it in 5 quarters. The position peaked at $1.04M in Q4 2020. 274 funds tracked by Wall St. Rank hold TXG as of Q1 2025.

  • FORA Capital reported no remaining 10x Genomics position as of Q1 2025 after selling out during the quarter.
  • FORA Capital sold 24,677 10x Genomics shares in Q1 2025, an estimated $354K.
  • FORA Capital first reported a position in 10x Genomics in Q2 2020 and held it in 5 quarters.
  • FORA Capital's 10x Genomics position peaked at $1.04M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2025.

Based on FORA Capital's 13F filing for Q1 2025, filed 14 May 2025.